Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fed Conditions

NCT00872235 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: fixed-dose combination of quinapril 20 mg and hydrochlorothiazide 25 mg tablets

Sponsor

Ranbaxy Laboratories Limited